Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor-tyrosine kinase inhibitor resistance subclones. [PDF]
Yu N+9 more
europepmc +1 more source
Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. [PDF]
Gerard A. Rodrigues, M Park
openalex +1 more source
Novel Para-Phenylenediamine-Based Derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization. [PDF]
Smaldone G+17 more
europepmc +1 more source
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.
B. I. Terman+6 more
semanticscholar +1 more source
Resistance patterns of non-small cell lung cancer treated with third-generation epidermal growth factor receptor-tyrosine kinase inhibitors. [PDF]
Chen N+6 more
europepmc +1 more source
Identification of C-mannosylation in a receptor tyrosine kinase AXL. [PDF]
Mori K+10 more
europepmc +1 more source
The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancer. [PDF]
Sattler M, Salgia R.
europepmc +1 more source